Medicine Archives

Sean Ahrens at FutureMed: How Crohnology Is Fueling the Patient Revolution

crohnology data Sean Ahrens at FutureMed: How Crohnology Is Fueling the Patient RevolutionWhile speaking at FutureMed, Sean Ahrens explained his frustrations as a patient suffering from Crohn’s disease and his dissatisfaction with conventional treatments for the condition. To deal with the problem and to help others with Crohn’s or colitis, he created Crohnology, a patient-to-patient information sharing platform.

crohnology face Sean Ahrens at FutureMed: How Crohnology Is Fueling the Patient RevolutionAhrens explained how the platform fits into the broader context of the “patient revolution,” in which patients are becoming increasingly motivated to become active participants in their healthcare. This revolution is being fueled by mobile tools and social media, he said. And it is becoming necessary, as our healthcare system struggles to deal with rising cost pressures, an uptick in chronic conditions and as doctor–patient interaction becomes increasingly limited.

His Crohnology platform enables patients to share health and treatment information with each other, and to monitor the success of their treatments over time. This strategy enables patients to better deal with chronic conditions.

Many patients with chronic conditions such as Crohn’s have already turned into self experimenters. Ahrens himself fits into that mold, having intentionally infected himself with parasitic worms to see if they could help manage the disease. During his talk, he explained that he ordered a $3000 dose of the parasitic worms and created Crohnology, in part, to leave a “paper trail” to document the experiment.

Once the system was up and running, he used it to track his health over the course of an entire year and was able to gain a number of powerful insights from it. The system is even more powerful when it is opened up to a broader community of patients, he explained. “If we make better tools, we can make better conclusions.” The system can be used to collect many anecdotes from patients. After all, anecdotes are “data that we just haven’t scrubbed well yet,” he said.

Ahrens summarized his talk by saying: “The impact of these tools on health is going to be tantamount to the overthrow of media.”

Link: Crohnology…

FutureMed…

Award-Winning Author Talks Personalized Medicine at FutureMed

Award-Winning Author Talks Personalized Medicine at FutureMed

Noted journalist and author David Ewing Duncan kicked off the Wednesday session of FutureMed by discussing personalized medicine and his work on the Experimental Man Project. The experiment, which is “ongoing,” is what Duncan described as a “humanized” way to look at personalized medicine, which can be useful in explaining the technology to the masses. He argued that personalized medicine stands in stark contrast to traditional medicine, which is “one-size-fits-all” and tries to fit patients “into a box.”

Pharmaceuticals are one of the most-needed applications of personalized medicine, he said, and the response rates for many drugs are pretty dismal. For instance, antidepressants don’t work for about 40% of people because they aren’t targeted for specific demographics based on genomic data. There is a low response rate to oncology drugs right now, Duncan added, but “we are getting better at targeting the drug to the right physiology.”

Read More

NASA Biocapsule Implant Diagnoses and Treats Diseases Without Human Intervention

NASA Biocapsule Implant Diagnoses and Treats Diseases Without Human Intervention

Gizmodo has a fascinating story on an implant, the Biocapsule, developed by NASA to treat astronauts while they are on a space mission. The device, a small rod to be implanted under the skin before take-off, is made out of carbon nanotubes and is filled with cells that release a substance once a certain trigger activates them.

The cells are trapped withing the capsule, while substances are released by diffusion across the capsule wall, which is also the way nutritients can get in. The capsules could be capable of delivering multiple doses over a long period of time. The nanostructures are inert, making them well-tolerated by the body, and the Biocapsules themselves are inexpensive and easy to make.

Read More

Analogic Releases New BK Medical Ultrasounds

Analogic Releases New BK Medical Ultrasounds

Analogic has announced the worldwide launch of three new ultrasound systems from its subsidiary BK Medical, the Pro Focus UltraView 800, the Flex Focus 800, and the Flex Focus 500.

All three models sport the company’s “Quantum Technology” that provides high resolution visualization of the tissues.

Read More

Check-Cap X-ray Radar Pill Sliding Toward Commercial Introduction

Check-Cap X-ray Radar Pill Sliding Toward Commercial Introduction

GE has announced investing into an Israeli company called Check-Cap that’s developing swallowable endoscopic capsules for imaging the insides of the GI tract.  Check-Cap seems to be a direct competitor of the better known Given Imaging, also an Israeli firm, that’s been producing its own PillCams for visualizing everything from the esophagus to the small intestine and beyond.

While PillCams use light in the visible spectrum and a traditional image sensor, the Check-Cap delivers low energy X-rays that provide a much different look at the internal anatomy.  Because X-rays penetrate through soft material, food intake shouldn’t be a problem for the device, and all the typical preparation for a GI tract analysis may not have to apply.

Read More

Cardinal Health Releases Smart-Seal Surgical Mask

Cardinal Health Releases Smart-Seal Surgical Mask

Cardinal Health has made available its Smart-Seal surgical mask that improves both its fit and reduces interior fogging while providing a high level of filtration and resistance to liquids.

From the announcement:

Read More

Finding, Pushing Kidney Stones Using Ultrasound

Finding, Pushing Kidney Stones Using Ultrasound

Ultrasound has been a welcome tool for many years to break up kidney stones, but finding the stones still requires radiograph or CT imaging. Researchers from the University of Washington and the National Space Biomedical Research Institute (NSBRI) believe they developed a method of detecting renal calculi using a modified diagnostic ultrasound equipment found in every modern hospital. Moreover, once detected, they are able to apply ultrasound in a controlled way so as to be able to push the stones in a desired direction. This may create a new treatment option, allowing physicians to guide stones toward the kidney exit that are refusing to pass naturally.

Detection of the stones is done thanks to the unexplained “twinkling artifact” phenomena that makes stones sparkle under Doppler ultrasound. Because X-rays are not used in detection, patients and clinicians would be less exposed to radiation, and diagnosis could be done faster and right at the point of care.

Read More

Medgadget Exclusive: Interview with PathoGenetix and Sagentia about Rapid Microbial Detection Technology

Medgadget Exclusive: Interview with PathoGenetix and Sagentia about Rapid Microbial Detection Technology

Ever since the Danish bacteriologist Hans Christian Gram developed his eponymous test (the Gram stain) in 1882 to differentiate between types of bacteria, diagnostic tests have been integral to both public and individual health. The ability to rapidly and accurately detect microbes is becoming increasingly important given the emergence of diverse drug resistant strains, such as Methicillin-resistant Staphylococcus aureus (MRSA; Gram positive bacteria resembling purple grapes), as well as the length of time it currently takes to diagnose and treat certain infections (e.g. Mycobacterium tuberculosis, which cannot be detected via Gram stain but rather an acid-fast stain, has an incredibly slow doubling time which is why it can take weeks to accurately diagnose tuberculosis). In recent years genomic technologies have fortunately opened the doors for faster and more accurate detection of microbes than petri dish cultures and chemical staining can provide. Medgadget had the opportunity to interview two partner companies – PathoGenetix and Sagentia – that are developing a state-of-the-art Genome Sequence Scanning (GSS) technology, which promises to bring rapid microbial detection to the fields of microbial genomics research, food and product safety, and clinical infectious disease testing.

Shiv Gaglani, Medgadget: How many micro-organisms can be detected through the partnership technology?

Read More

The Future of InterVapor: Q&A with Uptake’s Chief Medical Officer Steven Kesten

The Future of InterVapor: Q&A with Uptake's Chief Medical Officer Steven Kesten

InterVapor, from Uptake Medical (Tustin, CA), is a non-surgical endoscopic lung volume reduction procedure that uses thermal ablation without leaving foreign materials in the lung. In clinical studies of patients with severe emphysema, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life. The company has now closed a Series C funding round, which will support commercialization of InterVapor for treatment of severe emphysema. This news comes on the heels of Uptake Medical receiving CE mark approval for InterVapor in September, completing the first commercial use of InterVapor in Germany in November, and recently announcing TGA approval for InterVapor to be marketed in Australia.

Steven Kesten, Chief Medical Officer at Uptake Medical, answered our questions about the company and its technology:

Read More